BDX Becton Dickinson
Becton Dickinson earnings company data as of 7:03 PM ET 10/28
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 5 Nov | EPS | 4.06 | — | — |
| Rev | $5.11B | — | — |
Insider trades
Open-market buys and sales by BDX's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $653K sold by 2 insiders outside a trading plan
- $2.1M sold by 3 insiders under 10b5-1 plans
-
Michael Feld EVP, Chief Revenue OfficerPlanned sale$15K 76 shares at $198.13 0.4% of stakeTraded Oct 26 Filed Oct 27
-
Michael Feld EVP, Chief Revenue OfficerPlanned sale$14K 76 shares at $183.70 0.4% of stakeTraded Sep 28 Filed Sep 29
-
Michael Feld EVP, Chief Revenue OfficerPlanned sale$31K 165 shares at $188.49 0.8% of stakeTraded Aug 26 Filed Aug 27
-
Thomas E Polen Jr. CEOPlanned sale$768K 4,152 shares at $185.00 3.6% of stakeTraded Aug 13 Filed Aug 14
-
Roland Goette EVP and President, EMEASale$441K 2,438 shares at $180.84 14% of stakeTraded Aug 11 Filed Aug 12
-
Michael Feld EVP, Chief Revenue OfficerPlanned sale$12K 75 shares at $157.13 0.4% of stakeTraded Jul 27 Filed Jul 28
-
Michael Feld EVP, Chief Revenue OfficerPlanned sale$11K 75 shares at $152.80 0.4% of stakeTraded Jun 26 Filed Jun 26
-
Michael David Garrison EVP & Pres Med.Essntl&BioPharmPlanned sale$160K 1,100 shares at $145.66 7.7% of stakeTraded Jun 24 Filed Jun 25
-
Michael David Garrison EVP & Pres Med.Essntl&BioPharmPlanned sale$167K 1,100 shares at $151.48 7.2% of stakeTraded Jun 10 Filed Jun 11
-
Thomas E Polen Jr. CEOPlanned sale$405K 2,764 shares at $146.35 2.4% of stakeTraded Jun 1 Filed Jun 3
-
Michael Feld EVP, Chief Revenue OfficerPlanned sale$11K 75 shares at $147.35 0.4% of stakeTraded May 26 Filed May 27
-
Michael Feld EVP, Chief Revenue OfficerPlanned sale$11K 74 shares at $151.94 0.3% of stakeTraded Apr 27 Filed Apr 28
-
Michael Feld EVP, Chief Revenue OfficerPlanned sale$12K 75 shares at $156.83 0.4% of stakeTraded Mar 26 Filed Mar 27
-
Michael Feld EVP, Chief Revenue OfficerPlanned sale$14K 75 shares at $181.84 0.4% of stakeTraded Feb 26 Filed Feb 27
-
Bertram L Scott DirectorSale$174K 953 shares at $182.61 2.5% of stakeTraded Feb 18 Filed Feb 18
Also filed in the last 12 months, not counted as buying or selling: 36 stock grants, 14 share withholdings for taxes, 3 sales back to the company, and 3 option exercises.
SEC filings
Recent issuer filings from EDGAR, 18 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 5.02,7.01,9.01 | Filing Doc | |
| 8-K | 7.01 | Filing Doc | |
| 8-K | 1.01,2.03,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 424B2 | Filing Doc | ||
| 8-K | 8.01,9.01 | Filing Doc | |
| 424B2 | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K/A | 5.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 5.03,9.01 | Filing Doc | |
| 8-K | 5.02,7.01,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.